Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review
Conclusions
The evidence supports a clinical utility for HPV genotyping in risk discrimination during cervical cancer screening.
Source: Journal of Lower Genital Tract Disease - Category: OBGYN Tags: Cervical Disease Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Colposcopy | Conferences | Cytology | Genital Warts | Human Papillomavirus (HPV) | OBGYN | Study